Will continue taking anatabine as long as it is available, but will switch to MYMD-1 if it becomes available as a drug, since it will likely be covered by insurance.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.